Lipid Logic- Test Your Knowledge Webinar

 

Program Overview
Join the NLA to Test Your Knowledge! Our panel will explore current and emerging pharmacologic management options for special populations with dyslipidemia. Panelists will present a series of questions, you will make your selection on what you think the correct answer is and receive real-time critiques from our panel. We will explore expert recommendations for statin therapy, new evidence for non-statin therapy, and special populations. Register below to join us for this interactive webinar on September 11, 2020 from 12:00 – 1:00 PM Eastern! We hope to see you there!

 

Objectives & Accreditation

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live Internet Activity
Knowledge

Educational Objectives
At the conclusion of this activity, all participants should be able to:

• Appraise current and emerging pharmacologic management options for dyslipidemia.
• Appraise current and emerging management options for special populations with dyslipidemia.

CRITERIA FOR SUCCESS
Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. Partial credit may be awarded for ACPE credit.  A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/LipidLogic. The deadline to claim credit is October 9, 2020.

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

*IMPORTANT*
Pharmacists MUST request credit before November 2, 2020. Credit requested after this date will be subject to a fee.

COMMERCIAL SUPPORT
This activity is supported by educational funding provided by Medicure.

CREDIT DESIGNATION

CME/CE credit provided by the National Lipid Association
In support of improving patient care, The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-20-018-L01-P (Knowledge)
This Activity has been approved for 1.00 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
The maximum number of hours awarded for this CE activity is 1.0 contact hours.
For the advanced practice nurse, pharmacotherapy contact hours will be determined on your certificate.

DISCLOSURE INFORMATION

FACULTY, PLANNERS, & MODERATORS
Karen Aspry, MD, FNLA
President, Northeast Lipid Association
Lifespan Cardiovascular Institute
East Greenwich, RI
Contracted Research: Akcea, Amgen, Esperion

Dave L. Dixon, PharmD, CLS, FNLA
President, Southeast Lipid Association
Associate Professor
Vice-Chair of Clinical Services
Director, Center for Pharmacy Practice Innovation
VCU School of Pharmacy
Richmond, VA
Has nothing to disclose.

Joseph J. Saseen, PharmD, CLS, FNLA
President, National Lipid Association
Professor and Vice Chair, Clinical Pharmacy
Professor, Family Medicine
University of Colorado Anschutz Medical Campus
Aurora, CO
Has nothing to disclose.

Staff Disclosures

NLA Staff
Has nothing to disclose.

NLA CME Committee Reviewers
Susan Halli Demeter, DNP
Has nothing to disclose.

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME. 

DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.